Rapid Dose Therapeutics Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RDTCF research report →
About the company
Rapid Dose Therapeutics Corp. , a life sciences enterprise based in Burlington, Canada, specializes in cutting-edge drug delivery systems aimed at enhancing health and well-being for individuals across Canada. Their core offering is the QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds—such as pharmaceuticals, emulsified oils, and over-the-counter remedies—directly into the bloodstream.
- CEO
- Mark Andrew Upsdell
- IPO
- 2019
- Employees
- 12
- HQ
- Burlington, ON, CA
Price Chart
- Market Cap
- $10.46M
- P/E
- -3.49
- P/S
- 5.12
- P/B
- -1.98
- EV/EBITDA
- -11.77
- Div Yield
- 0.00%
- Gross Margin
- 10.13%
- Op Margin
- -78.29%
- Net Margin
- -122.22%
- ROE
- 54.18%
- ROIC
- 117.10%
- Revenue
- $2.77M · 33.00%
- Net Income
- $-3,389,667 · 37.28%
- EPS
- $-0.03 · 36.25%
- Op Income
- $-1,657,772
- FCF YoY
- 76.46%
- 52W High
- $0.15
- 52W Low
- $0.01
- 50D MA
- $0.06
- 200D MA
- $0.10
- Beta
- -0.91
- Avg Volume
- 1.34K
Get TickerSpark's AI analysis on RDTCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RDTCF coverage
Recent articles, reports, and earnings notes.
No research on RDTCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RDTCF report →Similar companies
Peers in the same neighborhood.